Loading…
4D Molecular Therapeutics, Inc. is projected to rise to $9.70 by 2027, a +10% move from its current price of $8.85. FDMT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $8.56 | $8.85 | $9.16 | +0.06% |
| May 30 | $8.45 | $8.86 | $9.29 | +0.11% |
| May 31 | $8.36 | $8.86 | $9.40 | +0.17% |
| Jun 1 | $8.29 | $8.87 | $9.49 | +0.22% |
| Jun 2 | $8.23 | $8.87 | $9.57 | +0.28% |
| Jun 3 | $8.18 | $8.88 | $9.64 | +0.33% |
| Jun 4 | $8.13 | $8.88 | $9.71 | +0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.13 | $8.88 | $9.71 | +0.39% |
| Week 2 | $7.86 | $8.92 | $10.12 | +0.78% |
| Week 3 | $7.67 | $8.95 | $10.45 | +1.17% |
| Week 4 | $7.52 | $8.99 | $10.74 | +1.56% |
| Week 5 | $7.39 | $9.02 | $11.01 | +1.95% |
| Week 6 | $7.28 | $9.06 | $11.27 | +2.35% |
| Week 7 | $7.18 | $9.09 | $11.51 | +2.74% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
4D Molecular Therapeutics, Inc. is a late-stage biotechnology company that develops adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company specializes in delivering multi-year sustained production of therapeutic agents in the retina, with its lead product candidate being 4D-150 for the treatment of retinal vascular diseases, including wet age-related macular degeneration and diabetic macular edema, delivered by intravitreal injection.
The company was founded in 2013 and is headquartered in EmeryVille, California. It has collaboration and licensing agreements with Otsuka Pharmaceutical Co., Ltd.
FDMT is a healthcare stock with a current price of $8.60 and a market cap of $449.58M. It is ranked 3121 by market capitalization among listed assets. The price outlook is informed by a multi-year forecast that projects rising averages and growing returns through 2050.
The forecast implies a path from a 2026 average of $8.60 to a 2050 average of $54.39, with substantial upside potential reflected in later-year ROIs.
A major floor 21.9% below — a decisive break under it would weaken the trend.
The nearest floor, 5.5% below — buyers have tended to step in here.
The nearest ceiling, 21.9% above — a clean break opens room to run.
A major ceiling 32.9% above — clearing it would confirm fresh momentum.
Key FDMT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FDMT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.66 | Buy | $8.76 | Buy |
| MA 10 | $8.95 | Sell | $8.95 | Sell |
| MA 20 | $9.35 | Sell | $9.21 | Sell |
| MA 50 | $9.49 | Sell | $9.34 | Sell |
| MA 100 | $9.05 | Sell | $9.21 | Sell |
| MA 200 | $9.03 | Sell | $8.83 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.34 | Neutral |
| Stoch RSI (14) | 26.90 | Neutral |
| CCI (20) | -48.77 | Neutral |
| Williams %R (14) | -80.00 | Info |
| MACD (12,26,9) | -0.12 | Sell |
| ROC (12) | -12.72 | Sell |
| Bollinger %B (20,2) | 0.34 | Neutral |
| Stochastic %K (14) | 20.00 | Neutral |
| TRIX (15) | -0.20 | Sell |
| Awesome (5,34) | -0.87 | Sell |
| Ultimate (7,14,28) | 38.27 | Neutral |
| Momentum (10) | -1.49 | Sell |
| Aroon Osc (25) | -20.00 | Sell |
| Hull MA (9) | 8.66 | Buy |
| ADX (14) | 14.04 | Neutral |
| ATR (14) | 0.30 | Info |
The 30-day technical picture is NEUTRAL. The RSI(14) is 40, indicating modest bullish or bearish pressure without a decisive swing. The 50-day simple moving average is $9.47 and the 200-day simple moving average is $9.00, providing nearby support and resistance context.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.19 | $8.85 | $11.48 | 0% | Neutral | |
| $7.52 | $9.70 | $13.36 | +10% | Neutral | |
| $7.57 | $10.11 | $14.53 | +14% | Neutral | |
| $8.60 | $11.82 | $17.56 | +34% | Bullish | |
| $10.75 | $15.16 | $23.16 | +71% | Bullish | |
| $11.15 | $16.11 | $25.23 | +82% | Bullish | |
| $11.63 | $17.18 | $27.51 | +94% | Bullish | |
| $11.97 | $18.05 | $29.49 | +104% | Bullish | |
| $11.70 | $18.01 | $29.96 | +104% | Bullish | |
| $12.04 | $18.89 | $31.96 | +113% | Bullish | |
| $17.66 | $30.29 | $55.02 | +242% | Bullish | |
| $30.59 | $61.49 | $123.70 | +595% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $7.19 | $8.85 | $10.40 | +0.00% |
| June 2026 | $7.64 | $9.01 | $10.93 | +1.85% |
| July 2026 | $7.80 | $9.31 | $11.47 | +3.26% |
| August 2026 | $7.61 | $9.15 | $11.42 | -1.71% |
| September 2026 | $7.49 | $9.07 | $11.44 | -0.81% |
| October 2026 | $7.69 | $9.37 | $11.92 | +3.25% |
| November 2026 | $7.61 | $9.33 | $11.96 | -0.46% |
| December 2026 | $7.21 | $8.88 | $11.48 | -4.75% |
Click any year to see its month-by-month FDMT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
4D Molecular Therapeutics, Inc.'s 2026 outlook centres on $8.85, within a $7.19 to $11.48 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, FDMT could reach as high as $13.36, with a base case around $9.70 and support toward $7.52 — roughly +10% from $8.85. A consolidation phase looks the most probable path here.
Expect FDMT to range from $7.57 to $14.53 through 2028. The $10.11 average target implies a +14% move from current prices. That is up +4% on the projected 2027 average. Price action looks broadly range-bound.
The FDMT price prediction for 2029 points to an average of $11.82 (low $8.60, high $17.56) — a potential gain of +34% on today's $8.85. Buyers look set to stay in control over this stretch.
In 2030, FDMT is projected to trade between $10.75 and $23.16, averaging $15.16 — a potential gain of +71% from today's $8.85. That is up +28% on the projected 2029 average. Momentum favours further upside here.
4D Molecular Therapeutics, Inc.'s 2031 outlook centres on $16.11, within a $11.15 to $25.23 range. That is up +6% on the projected 2030 average. That marks a +82% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, FDMT could reach as high as $27.51, with a base case around $17.18 and support toward $11.63 — roughly +94% from $8.85. Momentum favours further upside here.
Expect FDMT to range from $11.97 to $29.49 through 2033. The $18.05 average target implies a +104% move from current prices. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The FDMT price prediction for 2034 points to an average of $18.01 (low $11.70, high $29.96) — a potential gain of +104% on today's $8.85. Momentum favours further upside here.
In 2035, FDMT is projected to trade between $12.04 and $31.96, averaging $18.89 — a potential gain of +113% from today's $8.85. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
4D Molecular Therapeutics, Inc.'s 2040 outlook centres on $30.29, within a $17.66 to $55.02 range. That is up +60% on the projected 2035 average. That marks a +242% change versus current levels. Momentum favours further upside here.
By 2050, FDMT could reach as high as $123.70, with a base case around $61.49 and support toward $30.59 — roughly +595% from $8.85. Buyers look set to stay in control over this stretch.
Investing $1,000 in FDMT today (≈ 112.99435 FDMT) could be worth
$6,948.51
+$5,948.51 (+595%) by 2050 · US Dollar
Based on the average projected FDMT price of $61.49 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FDMTwould be worth at today's price.
$1,000 invested in FDMT on May 27, 2025 (≈ 292.397654 FDMT) would be worth
$2,587.72
+$1,587.72 (+158.8%) today · 2.59× · US Dollar
Based on a FDMT entry price of $3.42 vs. today's $8.85.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.47 | $1,044.86 | +4.5% |
| 1 month ago | $9.45 | $936.51 | -6.3% |
| 3 months ago | $9.66 | $916.15 | -8.4% |
| 6 months ago | $11.66 | $759.01 | -24.1% |
| 1 year ago | $3.42 | $2,587.72 | +158.8% |
| All time (5.0y) ago | $27.22 | $325.13 | -67.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FDMT forecast.
Our base-case forecast reaches $18.00 around 2033.
Implied market cap at $18.00: $940.97M
The multi-year forecast shows a gradual rise in average prices with a shift to bullish sentiment in the later years. In 2026 the average is $8.60 (min $7.19, max $11.07) with ROI 0 and NEUTRAL sentiment. By 2027 the average is $9.31 with ROI 8.3 and NEUTRAL sentiment, and by 2028 the average is $9.51 with ROI 10.6 and NEUTRAL sentiment.
In 2029 the average climbs to $10.98 with ROI 27.7 and is marked as BULLISH. The 2030 average is $14.25 with ROI 65.7 and BULLISH sentiment, followed by 2031 at $14.96 (ROI 74), 2032 at $15.92 (ROI 85.1), 2033 at $16.79 (ROI 95.2), 2034 at $16.31 (ROI 89.6), and 2035 at $17.04 (ROI 98.1), all with BULLISH sentiment. The forecast accelerates in the long horizon, with 2040 averaging $27.18 (ROI 216.1) and 2050 averaging $54.39 (ROI 532.4), both labeled BULLISH.
These figures are estimates and not guarantees, and they reflect the model’s projected path for price and return over time.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $14.25 with a min of $9.98 and a max of $22.07; ROI of 65.7% and sentiment BULLISH.
The forecast indicates rising average prices through 2029–2050 with bullish sentiment in later years and a long-term ROI up to 532.4% by 2050. Remember, these are estimates and not guarantees.
The 2030 forecast max is $22.07, with an average of $14.25, so reaching $20 is within the forecasted maximum for 2030.
Current price is $8.60 and market cap is $449.58M.
The forecast data lists an annualized volatility of 70%, reflecting expected price variation over time.
4D Molecular Therapeutics, Inc. Community Discussion
0Share your 4D Molecular Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.